Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US6485964

Title:TRANSGENIC MAMMALS LACKING EXPRESSION OF ERYTHROPOIETIN OR OF ERYTHROPOIETIN RECEPTOR, TRANSGENIC MAMMALS EXPRESSING CHIMERIC ERYTHROPOIETIN RECEPTORS, CONSTRUCTS FOR PRODUCING THE TRANSGENIC MAMMALS AND USES THEREFOR
Inventors:Wu, Hong; Brookline, MA, USA
Liu, Xin; Brookline, MA, USA
Lodish, Harvey F.; Brookline, MA, USA
Giebel, Lutz B.; San Mateo, CA, USA
Ross, Michael J.; Hillsborough, CA, USA
Matthews, David; San Francisco, CA, USA
Summary:This invention introduces novel DNA constructs having specific fragments of erythropoietin (Epo) or an Epo receptor gene and selectable marker, and the resulting transgenic nonhuman mammals. Described herein are transgenic mice lacking erythropoietin expression, in which the erythropoietin receptor is deleted, and which carry a heterologous erythropoietin receptor such as a chimeric receptor. Further disclosed are the methods by which such transgenic mice are produced, along with methods for the production of embryonic stem cells containing such constructs, and methods for identifying erythropoietin mimics or mimetics.
Abstract:Transgenic nonhuman mammals, such as transgenic mice, which lack erythropoietin expression, in which the erythropoietin receptor is deleted, which carry a heterologous erythropoietin receptor (e.g., a chimeric receptor); constructs useful for producing such transgenic nonhuman mammals, embryonic stem cells containing the constructs, a method of producing the transgenic nonhuman mammals and a method of identifying erythropoietin mimics or mimetics.
US Patent Website:Click Here for Full Text of Patent
Title Number:US6485964
Application Number:US1997000839605
Date Filed:15/04/1997
Date Published:26/11/2002
Assignee:Arris Pharmaceutical Corporation, South San Francisco, CA, USA Whitehead Institute for Biomedical Research, Cambridge, MA, USA


 
Copyright © 2007 The Institute for Cellular Medicine  8/13/2020